Search results

ANSTO will be participating in a new Industrial Transformation Training Centre established and funded by the Australia Research Council to advance the use of bioactive ingredients in Australia.

Human health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

International collaboration uses Australian Synchrotron on pioneering malaria research.

Project focuses on enhancing crop productivity in Asia Pacific countries by improving soil and water.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

Combining resources and expertise to address climate change in the Asia-Pacific

Researchers from Murdoch University and associated collaborators are using ANSTO’s unique nuclear capabilities to gain detailed information about how wheat crops take in administered micronutrients to maximise their efficient use.

Melbourne researchers map the structure of a key COVID-19 protein using the Australian Synchrotron

X-ray crystallography at the Australian Synchrotron contributed to major research findings.

In Australia and the Southeast Asia basin, the ANSTO facility offers a wide range of unique nuclear-beam techniques for cultural heritage research.

Planning is now underway for a second repatriation project which is scheduled to take place in 2022. Find out more information.

Dr Anna Paradowska has been appointed as a Conjoint Professor of Practice in Advanced Structural Materials at the University of Sydney.